CA9 and breast carcinoma: In line with this, application of an antibody against the CAIX binding site of CD147 removed CAIX from the transporter-chaperon complex, as shown by in situ PLA, decreased MCT transport activity in hypoxic breast cancer cells, and inhibited glycolytic activity as well as cell proliferation [117].